ImmediapressDaiichi Sankyo Presents Positive Results of the ENTRUST-AF PCI Study of LIXIANA®▼ (edoxaban) in Patients with Atrial Fibrillation Di Redazione - 4 Settembre 2019 CondividiFacebook Twitter WhatsApp Linkedin Email Print Telegram